| Human |
hsa_circ_MAN1A2 |
- |
MAN1A2 / chr1:117944808-117963271 |
colorectal cancer |
MAN1A2 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
nasopharyngeal carcinoma |
MAN1A2 |
hsa-miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
oral cavity carcinoma |
MAN1A2 |
hsa-miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
thyroid cancer |
MAN1A2 |
hsa-miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
ovarian cancer |
MAN1A2 |
hsa-miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
lung cancer |
MAN1A2 |
hsa-miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circ_0000119 |
cervical cancer |
MAN1A2 |
miR-433-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circ_0000119 |
gastric cancer |
MAN1A2 |
miR-502-5p |
Q
H
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0013747 |
- |
IgA glomerulonephritis |
MAN1A2 |
miR-330-3p |
Q
H
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0013729 |
hsa_circ-MAN1A2_001 |
gastric cancer |
MAN1A2 |
miR-361-3p |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
gastric cancer |
MAN1A2 |
miR-1236-3p |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circ_0000119 |
amyotrophic lateral sclerosis |
MAN1A2 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circ_00007_MAN1A2 |
COVID-19 |
MAN1A2 |
- |
S
| DN |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
breast cancer |
MAN1A2 |
- |
Q
| DS |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circMAN1A2 |
nasopharyngeal carcinoma |
MAN1A2 |
miR-940 |
Q
H
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 / circ-MAN1A2 |
ovarian cancer |
MAN1A2 |
miR-135a-3p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circMAN1A2_009 |
cervical adenocarcinoma |
MAN1A2 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
plasma cell myeloma |
MAN1A2 |
- |
S
| UN |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000118 |
circMAN1A2 |
gastric cancer |
MAN1A2 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000118 |
circMAN1A2 |
glioblastoma |
MAN1A2 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000118 |
circMAN1A2 / mmu_circ_001029 |
amyotrophic lateral sclerosis |
MAN1A2 |
- |
Q
| DS |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2(2,3,4,5) |
colorectal cancer |
MAN1A2 |
- |
Q
B
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000118 |
- |
atrial fibrillation |
MAN1A2 |
miR-34a-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
hsa_circMAN1A2_008 / circ-MAN1A2 |
esophageal squamous cell carcinoma |
MAN1A2 |
- |
Q
| UN |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circRNA mannosidase alpha class 1A member 2 |
thyroid gland papillary carcinoma |
MAN1A2 |
miR-449a |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
hsa_circ_0000119 |
circMAN1A2 |
ovarian cancer |
MAN1A2 |
miR-142-5p |
Q
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
nasopharyngeal carcinoma |
MAN1A2 |
miR-135a-3p |
Q
B
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circRNA mannosidase alpha class 1A member 2 / circMAN1A2 |
esophageal squamous cell carcinoma |
MAN1A2 |
- |
Q
H
| UP |
More |
| Human |
hsa_circ_MAN1A2 |
- |
circMAN1A2 |
myelodysplastic syndrome |
MAN1A2 |
Hsa-miR-409-3p, hsa-miR-579-5p, hsa-miR-1238-3p |
S
| UP |
More |